Kaye S - Search Results

1

Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals.

Fox J, Hill S, Kaye S, Dustan S, McClure M, Fidler S, Mackie NE. Fox J, et al. Among authors: kaye s. AIDS. 2007 Jan 11;21(2):237-9. doi: 10.1097/01.aids.0000247577.26375.ef. AIDS. 2007. PMID: 17197816

2

Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia.

Mackie NE, Phillips AN, Kaye S, Booth C, Geretti AM. Mackie NE, et al. Among authors: kaye s. J Infect Dis. 2010 May 1;201(9):1303-7. doi: 10.1086/651618. J Infect Dis. 2010. PMID: 20350161

3

The effect of transmitted HIV-1 drug resistance on pre-therapy viral load.

Harrison L, Castro H, Cane P, Pillay D, Booth C, Phillips A, Geretti AM, Dunn D; UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study (UK CHIC). Harrison L, et al. AIDS. 2010 Jul 31;24(12):1917-22. doi: 10.1097/QAD.0b013e32833c1d93. AIDS. 2010. PMID: 20588166

4

Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK.

Fox J, Castro H, Kaye S, McClure M, Weber JN, Fidler S; UK Collaborative Group on HIV Drug Resistance. Fox J, et al. Among authors: kaye s. AIDS. 2010 Sep 24;24(15):2397-401. doi: 10.1097/QAD.0b013e32833cbb5b. AIDS. 2010. PMID: 20634664

5

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.

Hamlyn E, Hickling S, Porter K, Frater J, Phillips R, Robinson M, Mackie NE, Kaye S, McClure M, Fidler S; SPARTAC Investigators. Hamlyn E, et al. Among authors: kaye s. AIDS. 2012 Apr 24;26(7):887-90. doi: 10.1097/QAD.0b013e328351e721. AIDS. 2012. PMID: 22313951

6

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults.

Mackie NE, Dunn DT, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C, Geretti AM; UK HIV Drug Resistance Database; UK CHIC study. Mackie NE, et al. AIDS. 2013 Sep 10;27(14):2245-53. doi: 10.1097/QAD.0b013e3283636179. AIDS. 2013. PMID: 24157905

7

The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the United Kingdom.

Green H, Tilston P, Fearnhill E, Pillay D, Dunn DT; UK Collaborative Group on HIV Drug Resistance. Green H, et al. J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):196-204. doi: 10.1097/QAI.0b013e318185725f. J Acquir Immune Defic Syndr. 2008. PMID: 18769348

8

Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naïve individuals.

Hué S, Gifford RJ, Dunn D, Fernhill E, Pillay D; UK Collaborative Group on HIV Drug Resistance. Hué S, et al. J Virol. 2009 Mar;83(6):2645-54. doi: 10.1128/JVI.01556-08. Epub 2009 Jan 21. J Virol. 2009. PMID: 19158238 Free PMC article.

9

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom.

Chilton DN, Castro H, Lattimore S, Harrison LJ, Fearnhill E, Delpech V, Rice B, Pillay D, Dunn DT; UK Collaborative Group on HIV Drug Resistance. Chilton DN, et al. Antivir Ther. 2010;15(7):985-91. doi: 10.3851/IMP1658. Antivir Ther. 2010. PMID: 21041913

10

The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK.

Donegan KL, Walker AS, Dunn D, Judd A, Pillay D, Menson E, Lyall H, Tudor-Williams G, Gibb DM; Collaborative HIV Paediatric Study; UK HIV Drug Resistance Database. Donegan KL, et al. Antivir Ther. 2012;17(4):599-603. doi: 10.3851/IMP2015. Epub 2011 Dec 15. Antivir Ther. 2012. PMID: 22300840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,502 results

Search Page

Filters